Q4 2025 earnings call recap: clonoSEQ MRD growth, 2026 revenue guidance, margins, cash burn and risks—read now.
Qualcomm Q1 2026 earnings call recap: record revenue/EPS, Q2 guidance, handset DRAM shortages, and automotive & IoT growth outlook.
8hon MSN
Biogen outlines $15.25-$16.25 EPS guidance for 2026 while advancing growth products and pipeline
Q4 2025 Management View Christopher Viehbacher, President, CEO & Director, opened by stating, "We finished the year strongly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results